J. Jereb

发表

Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

B. Metchock, G. Mazurek, M. Iademarco, 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

American Thoracic Society Documents An Official ATS Statement : Hepatotoxicity of Antituberculosis Therapy

T. Sterling, J. Jereb, S. Schenker, 2006 .

Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis.

J. Duchin, I. Onorato, C. Nolan, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.

K. Powell, S. Goldberg, P. Lobue, 2011, MMWR. Morbidity and mortality weekly report.

A MODEL FOR INTERVAL‐CENSORED TUBERCULOSIS OUTBREAK DATA

Theodore J. Thompson, T. Thompson, J. Jereb, 1997 .

High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection

T. Chorba, M. Lobato, J. Jereb, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.

K. Castro, P. Mcelroy, K. Ijaz, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands

S. Bamrah Morris, C. Daley, T. Chorba, 2016, The Pediatric infectious disease journal.

Tuberculosis in Indigenous Peoples in the U.S., 2003–2008

T. Holtz, J. Cheek, J. Jereb, 2011, Public health reports.

Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence.

K. Powell, J. Jereb, J. Saukkonen, 2012, American journal of respiratory and critical care medicine.

Tuberculosis associated with therapy against tumor necrosis factor alpha.

K. Winthrop, M. Iademarco, J. Jereb, 2005, Arthritis and rheumatism.

PandemicInfluenza:ImplicationsforProgramsControlling forHIVInfection,Tuberculosis,andChronicViralHepatitis

C. Kent, R. Lynfield, P. Peters, 2009 .

Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.

C. Kent, R. Lynfield, P. Peters, 2009, American journal of public health.

System Failure versus Personal Accountability — The Case for Clean Hands

W. El-Sadr, L. Lambert, P. Jensen, 2006 .

Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates.

J. T. Crawford, M. Edmond, J. Dowling, 1993, The Journal of infectious diseases.

Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis.

V. Venkataramanan, J. Jereb, M. Marrone, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tuberculosis morbidity in the United States: final data, 1990.

D. Snider, S. Dooley, J. Jereb, 1991, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection - United States, 2004-2008.

K. Powell, T. Navin, J. Jereb, 2010, MMWR. Morbidity and mortality weekly report.

Interferon-γ release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children

M. Lobato, J. Jereb, D. Lewinsohn, 2010, Current opinion in pediatrics.

Hemoglobin E trait reexamined: a cause of microcytosis and erythrocytosis.

J. Jereb, V. Fairbanks, B. Brimhall, 1979, Blood.

Tuberculosis Contact Investigations--United States, 2003-2012.

R. Reves, T. Chorba, J. Jereb, 2016, MMWR. Morbidity and mortality weekly report.

Possible Airborne Person-to-Person Transmission of Mycobacterium bovis - Nebraska 2014-2015.

P. Iwen, B. Buss, J. Jereb, 2016, MMWR. Morbidity and mortality weekly report.

Transmission of Mycobacterium tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012

R. Reves, R. Belknap, J. Jereb, 2013, MMWR. Morbidity and mortality weekly report.

Interferon-γ release assays for prediction of tuberculosis.

J. Grinsdale, L. Kawamura, J. Jereb, 2012, The Lancet. Infectious diseases.

New Guidelines About Latent Tuberculosis Infection in Children and Adolescents: A Welcome Advancement

K. Castro, J. Jereb, L. Nelson, 2004, Pediatrics.

Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers.

J. T. Crawford, T. Frieden, S. Dooley, 1992, Annals of internal medicine.

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

J. Kaldor, K. Castro, S. Goldberg, 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Interruptions in Supplies of Second-Line Antituberculosis Drugs — United States, 2005–2012

T. Chorba, J. Jereb, B. Seaworth, 2013, MMWR. Morbidity and mortality weekly report.

Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection.

K. Castro, P. Mcelroy, L. Lambert, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis.

J. T. Crawford, V. Sharp, P. J. Smith, 1995, Archives of internal medicine.

Progressing toward tuberculosis elimination in low-incidence areas of the United States. Recommendations of the Advisory Council for the Elimination of Tuberculosis.

J. Jereb, 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Keeping It in the Family: the Childhood Burden of Tuberculosis

T. Chorba, J. Jereb, 2017, Emerging Infectious Diseases.

Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999.

J. Jereb, O. Joglar, M. Moore, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection.

K. Castro, P. Mcelroy, L. Lambert, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection.

K. Castro, J. Jereb, D. Cohn, 2003, Chest.

Do We Have Evidence for Policy Changes in the Treatment of Children With Latent Tuberculosis Infection?

K. Castro, M. Lobato, J. Jereb, 2009, Pediatrics.

Directly observed therapy and tuberculosis treatment completion. Jereb et al. re: Bayer et al.

I. Onorato, J. Jereb, P. Simone, 1999, American journal of public health.

A model for interval-censored tuberculosis outbreak data.

T. Thompson, J. Jereb, P. J. Smith, 1997, Statistics in medicine.

False positive diagnoses of multidrug resistant tuberculosis due to laboratory contamination

I. Onorato, S. Valway, S. Dooley, 1994 .

Nosocomial Transmission of Multidrug-resistant Mycobacterium tuberculosis

J. T. Crawford, T. Frieden, S. Dooley, 1992, Annals of Internal Medicine.

Unintended Consequences: Mandatory Tuberculin Skin Testing and Severe Isoniazid Hepatotoxicity

M. Lobato, J. Jereb, J. Starke, 2008, Pediatrics.

The Fog of War and the Declining Prevalence of Mental Retardation

K. Castro, J. Jereb, L. Nelson, 2016 .

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

K. Castro, S. Goldberg, G. Mazurek, 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Integrated Preparedness for Continuity of Tuberculosis Care after Hurricanes Gustav and Ike: Louisiana and Texas, 2008

C. Pozsik, J. Jereb, Charles Wallace, 2010, Public health reports.

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

K. Castro, S. Goldberg, G. Mazurek, 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999.

J. Jereb, O. Joglar, M. Moore, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Targeted tuberculin testing and treatment of latent tuberculosis infection - Supplement - American Thoracic Society Centers for Disease Control and Prevention

A. Vernon, J. Jereb, G. Migliori, 1999 .